CRISPR Therapeutics AG
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2015 | $247.0K | $-25.7M | $-25.5M |
| FY2016 | $5.2M | $-68.1M | $-23.2M |
| FY2017 | $41.0M | $-64.6M | $-68.4M |
| FY2018 | $3.1M | $-158.9M | $-165.0M |
| FY2019 | $289.6M | $46.7M | $66.9M |
| FY2020 | $719.0K | $-354.4M | $-348.9M |
| FY2021 | $915.0M | $373.5M | $377.7M |
| FY2022 | $1.2M | $-673.2M | $-650.2M |
| FY2023 | $371.2M | $-222.5M | $-153.6M |
| FY2024 | $37.3M | $-466.6M | $-366.3M |
| FY2025 | $3.5M | $-664.6M | $-581.6M |